natgillin/translations-raw huggingface dataset:
It is used for the treatment of adults and children over the age of two years with: invasive aspergillosis (a type of fungal infection due to Aspergillus); candidaemia (another type of fungal infection due to Candida) in non-neutropenic patients (patients with a normal white blood cell count); serious invasive Candida infections when the fungus is resistant to fluconazole (another antifungal medicine); serious fungal infections caused by Scedosporium or Fusarium (two different types of fungus).
Uporablja se pri odraslih in otrocih, starejših od dveh let, za zdravljenje: invazivne aspergiloze (vrste glivične okužbe, ki jo povzroča glivica Aspergillus); kandidemije (druge vrste glivične okužbe, ki jo povzroča Candida) pri nenevtropeničnih bolnikih (bolnikih z normalnimi ravnmi levkocitov v krvi), hude invazivne okužbe z glivico Candida, odporne proti flukonazolu (drugemu zdravilu proti glivicam); resne glivične okužbe, ki jih povzročata Scedosporium ali Fusarium (dve različni vrsti glivic).
It is used for the treatment of patients (adults and children over the age of 2) with: invasive aspergillosis (a type of fungal infection due to Aspergillus sp), candidaemia (another type of fungal infection due to Candida sp) in non-neutropenic patients (patients without abnormally low white blood cells count), serious invasive Candida sp.infections when the fungus is resistant to fluconazole (another antifungal medicine), serious fungal infections caused by Scedosporium sp.or Fusarium sp. (two different species of fungi).
Uporablja se za zdravljenje bolnikov (odraslih in otrok, starih 2 leti ali več): z invazivno aspergilozo (vrsta glivične okužbe, ki jo povzročajo vrste Aspergillus), s kandidemijo (druga vrsta glivične okužbe, ki jo povzročajo vrste Candida) pri nenevtropeničnih bolnikih (bolniki, ki nimajo nenormalno zmanjšanega števila belih krvnih celic), s hudimi invazivnimi okužbami, ki jih povzročajo vrste Candida, odporne na flukonazol (drugo protiglivično zdravilo), s hudimi glivičnimi okužbami, ki jih povzročajo vrste Scedosporium ali Fusarium (dve različni vrsti gliv).
It is used for the treatment of the following types of cancer: advanced AIDS-related Kaposi’s sarcoma (a skin cancer often found in AIDS patients), when treatment with anthracyclines (another type of anticancer medicine) has failed; metastatic breast cancer, when other treatments have failed or cannot be used. ‘Metastatic’ means that the cancer has spread to other parts of the body;
Uporablja se za zdravljenje naslednjih vrst raka: napredovalega Kaposijevega sarkoma, povezanega z AIDS-om (vrste raka kože, ki se pogosto pojavi pri bolnikih z AIDS-om), kjer zdravljenje z antraciklini (drugo vrsto zdravil proti raku) ni bilo uspešno,
It is used for treating and preventing bleeding in patients with von Willebrand disease (VWD, an inherited bleeding disorder caused by lack of von Willebrand factor) when another medicine called desmopressin is ineffective or cannot be given.
Uporablja se za zdravljenje in preprečevanje krvavenja pri bolnikih z von Willebrandovo boleznijo (VWD, dedno motnjo strjevanja krvi, ki jo povzroča pomanjkanje von Willebrandovega faktorja), kadar drugi zdravilo, imenovano dezmopresin, ni učinkovito ali ni primerno za uporabo.
It is used if the NSCLC is ‘ALK-positive’, which means that the cancer cells contain certain changes affecting the gene responsible for a protein called ALK (anaplastic lymphoma kinase).
Uporablja se le, če je nedrobnocelični pljučni rak ALK-pozitiven, kar pomeni, da rakave celice vsebujejo določene spremembe, ki vplivajo na gen, odgovoren za beljakovino, imenovano anaplastična limfomska kinaza (ALK).
It is used in addition to diet and exercise in the following ways:
Uporablja se kot dodatek k dieti in telesni dejavnosti na naslednje načine:
It is used in addition to diet and exercise.
Uporablja se kot dodatek dieti in telesni dejavnosti.
It is used in addition to levodopa (a medicine commonly used to treat the symptoms of Parkinson’s disease) either alone or in combination with other medicines for Parkinson’s, in patients with mid- to late-stage Parkinson’s disease who are having ‘motor fluctuations’.
Uporablja se kot dodatek k levodopi (zdravilu, ki se običajno uporablja za zdravljenje simptomov Parkinsonove bolezni), bodisi samostojno ali v kombinaciji z drugimi zdravili za zdravljenje Parkinsonove bolezni pri bolnikih z motoričnimi nihanji v srednji do pozni fazi bolezni.
It is used in adults (aged 18 years or over) who are at a low to moderate risk of rejection.
Uporablja se pri odraslih (starih 18 let ali več) z nizkim do zmernim tveganjem za zavrnitev.
It is used in adults and children as part of a ‘conditioning’ (preparative) treatment before transplantation of haematopoietic progenitor cells (the cells that make blood cells).
Uporablja se pri odraslih in otrocih kot del pripravljalnega zdravljenja pred presaditvijo krvotvornih matičnih celic (celic, ki tvorijo krvne celice).
It is used in adults and children from the age of 3 months to treat the following infections:
Uporablja se za odrasle in otroke, starejše od 3 mesecev, za zdravljenje naslednjih okužb:
It is used in adults for the treatment of the following inflammatory diseases:
ljudeh za zdravljenje naslednjih vnetnih bolezni:
It is used in adults who have compensated liver disease (when the liver is damaged but works normally), who also show signs that the virus is still multiplying; chronic hepatitis C (a disease of the liver due to infection with the hepatitis C virus).
Uporablja se pri odraslih, ki imajo kompenzirano jetrno bolezen (tj. poškodovana jetra, ki pa delujejo normalno), ki kažejo tudi znake, da se virus še vedno razmnožuje; kroničnim hepatitisom C (boleznijo jeter, ki je posledica okužbe z virusom hepatitisa C).
It is used in adults who have had a heart attack or have unstable angina (a type of chest pain caused by problems with the blood flow to the heart).
Uporablja se pri odraslih bolnikih po srčnem infarktu ali pri tistih z nestabilno angino (vrsto bolečine v prsnem košu zaradi težav s pretokom krvi v srce).
It is used in adults who have received at least two prior therapies, including both lenalidomide and bortezomib, and whose disease progressed after the last treatment.
Uporablja se pri odraslih, ki so predhodno prejeli vsaj dve zdravljenji, vključno z lenalidomidom in bortezomibom, in pri katerih je bolezen po zadnjem zdravljenju napredovala.
It is used in adults with manifestation of severe coronary insufficiency defined as spontaneous and recent chest pain with electrocardiographic abnormalities or biological changes.
Zdravilo Eptifibatide Accord se uporablja pri odraslih z znaki hude koronarne insuficience, ki je opredeljena kot nedavna spontana bolečina v prsih z nepravilnostmi v EKG ali biološkimi spremembami.
It is used in adults with manifestation of severe coronary insufficiency defined as spontaneous and recent chest pain with electrocardiographic abnormalities or biological changes.
Zdravilo Integrilin se uporablja pri odraslih z znaki hude koronarne insuficience, ki je opredeljena kot nedavna spontana bolečina v prsih z nepravilnostmi v EKG ali biološkimi spremembami.
It is used in adults with type 2 diabetes to control their blood glucose (sugar) level.
Uporablja za urejanje ravni glukoze (sladkorja) v krvi pri odraslih bolnikih s sladkorno boleznijo tipa 2.
It is used in adults with ‘open angle glaucoma’ or ocular hypertension who do not respond sufficiently to eye drops containing beta-blockers or prostaglandin analogues (other medicines used for these conditions).
Uporablja se pri odraslih z glavkomom odprtega zakotja ali očesno hipertenzijo, ki se ne odzivajo dovolj na kapljice za oči, ki vsebujejo antagoniste adrenergičnih receptorjev beta ali analoge prostaglandina (drugi vrsti zdravil, ki se uporabljajo za zdravljenje teh bolezni).
It is used in adults with ‘open angle glaucoma’ or ‘ocular hypertension’ who do not respond sufficiently to eye drops containing beta-blockers or prostaglandin analogues (other medicines used for these conditions).
Uporablja se pri odraslih z glavkomom odprtega zakotja ali okularno hipertenzijo, ki se ne odzivajo dovolj na očesne kapljice, ki vsebujejo zaviralce receptorjev beta ali analoge prostaglandina (drugi vrsti zdravila za zdravljenje teh bolezni).
It is used in adults, usually when other medicines or treatments have failed or cannot be used, for the treatment of the following diseases: rheumatoid arthritis (an immune-system disease causing inflammation of the joints).
Uporablja se pri odraslih, običajno takrat, ko druga zdravila ali načini zdravljenja niso bili uspešni ali jih ni mogoče uporabljati, za zdravljenje naslednjih bolezni: revmatoidnega artritisa (bolezni imunskega sistema, ki povzroča vnetje sklepov).
It is used in cattle to treat bovine respiratory disease (BRD) caused by the bacteria Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis.
Uporablja se pri govedu za zdravljenje respiratorne bolezni govedi (BRD), ki jo povzročajo bakterije Mannheimia haemolytica, Pasteurella multocida, Histophilus somni in Mycoplasma bovis.
It is used in children who have been newly diagnosed with Ph+ CML and who are not eligible for a bone marrow transplant.
Uporablja se pri otrocih z na novo ugotovljeno kronično mieloidno levkemijo s kromosomom Philadelphia, pri katerih presaditve kostnega mozga ni možno izvesti.
It is used in children with a body weight of at least 40 kg who have not responded adequately to treatment with methotrexate.
Uporablja se pri otrocih s telesno maso najmanj 40 kilogramov, ki se niso ustrezno odzvali na zdravljenje z metotreksatom.
It is used in combination with another anti-cancer medicine called vemurafenib.
Uporablja se v kombinaciji z drugim zdravilom proti raku, imenovanim vemurafenib.
It is used in combination with another medicine, methotrexate, when the disease has not responded adequately to other treatments called disease-modifying antirheumatic drugs (DMARDs), including methotrexate.
Uporablja se v kombinaciji z drugim zdravilom, tj. metotreksatom, pri bolnikih, ki se niso zadostno odzvali na zdravljenje z drugimi vrstami zdravil, imenovanimi imunomodulirajoča protirevmatična zdravila (DMARD), vključno z metotreksatom.
It is used in combination with dexamethasone (an anti-inflammatory medicine) to treat multiple myeloma (a cancer of the bone marrow).
Uporablja se v kombinaciji z deksametazonom (protivnetnim zdravilom) za zdravljenje multiplega mieloma (raka kostnega mozga).
It is used in combination with lenalidomide and dexamethasone.
Zdravilo uporabljamo v kombinaciji z lenalidomidom in deksametazonom.
It is used in combination with methotrexate (a medicine used to reduce inflammation) in patients who have not responded adequately to methotrexate alone; cryopyrin-associated periodic syndromes (CAPS) in patients from 8 months of age and weighing at least 10 kg.
Uporablja se v kombinaciji z metotreksatom (zdravilom za ublažitev vnetja) pri bolnikih z nezadostnim odzivom na metotreksat kot samostojno zdravilo; s kriopirinom povezanih periodičnih sindromov (CAPS) pri bolnikih, starih več kot osem mesecev in težkih vsaj 10 kg.
It is used in combination with methotrexate, when the disease has not responded adequately to DMARDs, including methotrexate.
Uporablja se v kombinaciji z metotreksatom pri bolnikih, ki se niso zadostno odzvali na zdravljenje z imunomodulirajočimi protirevmatičnimi zdravili (DMARD), vključno z metotreksatom.
It is used in combination with other antiviral medicines to treat adults and children infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Zdravilo se uporablja v kombinaciji z drugimi protivirusnimi zdravili za zdravljenje odraslih in otrok, okuženih z virusom humane imunske pomanjkljivosti tipa 1 (HIV-1), ki povzroča sindrom pridobljene imunske pomanjkljivosti (AIDS).
It is used in combination with other medicines in adults with compensated liver disease.
Pri odraslih s kompenzirano boleznijo jeter se uporablja skupaj z drugimi zdravili.
It is used in combination with prednisone or prednisolone (anti-inflammatory medicines) in patients who have previously been treated with docetaxel (another cancer medicine).
Uporablja se v kombinaciji s prednizonom ali prednizolonom (protivnetnima zdraviloma) pri bolnikih, ki so se že zdravili z docetakselom (drugim zdravilom proti raku).
It is used in combination with standard therapy including beta-blockers, or in patients who cannot be treated with beta-blockers.
Uporablja se v kombinaciji s standardnim zdravljenjem, ki vključuje zaviralce receptorjev beta, ali pri bolnikih, ki teh zaviralcev ne smejo jemati.
It is used in combination with standard therapy, including beta-blocker therapy or when beta- blockers are contraindicated or not tolerated.
Uporablja se v kombinaciji z običajnim zdravljenjem, vključno z zdravljenjem z antagonisti receptorjev beta oziroma ko je zdravljenje z antagonisti receptorjev beta kontraindicirano ali ga bolnik ne prenaša dobro.
It is used in combination with ‘protease inhibitor’ medicines taken together with ritonavir, and with other anti-HIV medicines in patients whose disease is not expected to be resistant to elvitegravir.
Uporablja se v kombinaciji z „zaviralci proteaze“, ki se jemljejo skupaj z ritonavirjem, in z drugimi zdravili proti okužbi z virusom HIV pri bolnikih, za katere se ne pričakuje, da bodo odporni na elvitegravir.
It is used in epilepsy with or without ‘secondary generalisation’ (when the excessive electrical activity reaches the whole brain).
Uporablja se pri epilepsiji s sekundarno generalizacijo (ko prekomerna električna aktivnost zajame celotne možgane) ali brez nje.
It is used in patients aged over 65 years, and in younger patients if they cannot be treated with high-dose chemotherapy (anticancer treatments).
Uporablja se pri bolnikih, starejših od 65 let, ter pri mlajših bolnikih, če zanje zdravljenje s kemoterapijo (zdravili za zdravljenje raka) v visokih odmerkih ni primerno.
It is used in patients already taking an oestrogen (a female sex hormone).
Uporablja se pri bolnicah, ki že jemljejo estrogen (ženski spolni hormon).
It is used in patients who are unable to exercise enough for the scan
Zdravilo se uporablja pri bolnikih, ki ne zmorejo telesne vadbe, potrebne za slikanje.
It is used in patients who cannot be treated with beta-blockers (another type of medicine to treat angina) or in combination with beta-blockers in patients whose disease is not controlled with them alone and whose heart rate is at least 70 beats per minute.
Uporablja se pri bolnikih, ki ne morejo jemati zaviralcev receptorjev beta (druge vrste zdravila za zdravljenje angine pektoris), oziroma v kombinaciji z zaviralci receptorjev beta pri bolnikih, pri katerih bolezen samo z jemanjem teh zaviralcev ni urejena in katerih srčni utrip je vsaj 70 udarcev na minuto.
It is used in patients who cannot be treated with beta‑blockers (another type of medicine to treat angina) or in combination with a beta blocker in patients whose disease is not controlled by beta blockers alone.
Uporablja se pri bolnikih, ki jih ni mogoče zdraviti z antagonisti adrenergičnih receptorjev beta (drugo vrsto zdravil za zdravljenje angine pektoris), ali v kombinaciji z antagonisti adrenergičnih receptorjev beta pri bolnikih, pri katerih bolezni ni mogoče nadzorovati s samostojnimi antagonisti adrenergičnih receptorjev beta.
It is used in patients who have already been treated with, or who cannot be given, other available treatments including chemotherapy based on medicines called fluoropyrimidines, oxaliplatin or irinotecan and treatment with other cancer medicines known as anti-VEGF and anti-EGFR.
Uporablja se pri bolnikih, ki so se predhodno že zdravili z drugimi zdravili, vključno s kemoterapijo na osnovi zdravil, imenovanih fluoropirimidini, oksaliplatin ali irinotekan, ali z drugimi zdravili proti raku, imenovanimi anti-VEGF in anti-EGFR, oziroma teh zdravil ne morejo prejemati.
It is used in patients who have at least one risk factor for events such as a heart attack or stroke, cannot take vitamin-K antagonists (other medicines that prevent blood clots) and are at low risk of bleeding.
Uporablja se pri bolnikih, ki imajo vsaj en dejavnik tveganja za dogodke, kot so srčni napad ali kap, ne smejo jemati antagonistov vitamina K (drugih zdravil, ki preprečujejo krvne strdke) in pri katerih je tveganje za krvavitve majhno.
It is used in patients who have one or more risk factors, such as having had a previous stroke, having high blood pressure, diabetes, heart failure or being 75 years old or over.
Uporablja se pri bolnikih z enim ali več dejavniki tveganja, kot so prejšnje kapi, visok krvni tlak, sladkorna bolezen, srčno popuščanje ali starost (75 let ali več).
It is used in patients with lymphoma or multiple myeloma (types of blood cell cancer) for autologous transplantation (when the patient’s own cells are used in the transplant).
Uporablja se pri bolnikih z limfomom ali multiplim mielomom (vrstama raka krvnih celic) za avtologno presaditev (v presadku so uporabljene bolnikove lastne celice).
It is used in patients with normal blood iron levels who could experience complications if they were to receive a blood transfusion, if they do not have the opportunity to donate their own blood before surgery and are expected to lose 900 to 1,800 ml of blood.
Zdravilo se uporablja pri bolnikih z normalnimi ravnmi železa, pri katerih lahko pride do zapletov v primeru prejema transfuzije krvi, če pred kirurškim posegom nimajo možnosti darovati lastne krvi, pričakovane izgube pa znašajo od 900 do 1 800 ml.
It is used in patients with: compensated liver disease (when the liver is damaged but functions normally), who also show signs that the virus is still multiplying, and have signs of liver damage (raised levels of the liver enzyme ‘alanine aminotransferase’ [ALT] and signs of damage when liver tissue is examined under a microscope).
Uporablja se pri bolnikih s: kompenzirano boleznijo jeter (jetra so poškodovana, a delujejo normalno) pri bolnikih, ki kažejo tudi znake še vedno potekajočega razmnoževanja virusa in znake poškodb jeter (povišane ravni jetrnega encima „alanin-aminotransferaze“ [ALT] in znake poškodb, ki so vidni pod mikroskopom).
It is used in patients with: compensated liver disease (when the liver is damaged but works normally), who also show signs that the virus is still multiplying and have signs of liver damage (raised levels of the liver enzyme alanine aminotransferase [ALT] and signs of damage when liver tissue is examined under a microscope).
Uporablja se pri bolnikih: s kompenzirano jetrno boleznijo (jetra so poškodovana, a delujejo normalno), ki kažejo tudi znake še vedno potekajočega razmnoževanja virusa in znake poškodb jeter (povišane ravni jetrnega encima alanin-aminotransferaze [ALT] in znake poškodb, ki so vidni pod mikroskopom).
It is used in people who have recently been diagnosed and who have not been prescribed another medicine for their multiple myeloma before, or who cannot be treated with high dose chemotherapy, which can be very difficult for the body to handle.
Uporablja se pri bolnikih, ki jim je bila ta diagnoza postavljena pred kratkim in ki za zdravljenje diseminiranega plazmocitoma še niso prejemali drugega zdravila ali ki ne morejo prejemati visokih odmerkov kemoterapije, ki jih telo lahko zelo težko prenaša.
It is used in people whose myeloma has become worse, despite having received at least two other kinds of treatment, including the medicines lenalidomide and bortezomib.
Uporablja se pri ljudeh, pri katerih se je plazmocitom poslabšal kljub temu, da so že bili vsaj dvakrat zdravljeni, vključno z zdraviloma lenalidomidom in bortezomibom.
It is used in those patients who have at least one risk factor for vascular events such as a heart attack or stroke, cannot take vitamin K antagonists (other medicines that prevent blood clots) and are at low risk of bleeding.
Uporablja se pri tistih bolnikih, ki imajo vsaj en dejavnik tveganja za vaskularne dogodke, kot so srčni napad ali možganska kap, ki ne smejo jemati antagonistov vitamina K (drugega zdravila, ki preprečuje krvne strdke) in pri katerih je tveganje za krvavitve majhno.
It is used in women before they undergo surgery on their fibroids and can also be used long-term but with treatment breaks in other women.
Pri njih se uporabi pred kirurškim posegom na leiomiomih, lahko pa se uporablja tudi dolgotrajno s prekinitvami zdravljenja pri drugih ženskah.
It is used in women who cannot use oestrogen therapy that is applied locally.
Predpisuje se ženskam, ki ne morejo uporabljati estrogenskega zdravila za lokalno uporabo.
It is used in ‘photodynamic therapy’, a method of treatment that uses light (generally from a laser) to activate a photosensitising agent.
Uporablja se pri „fotodinamični terapiji“, tj. metodi zdravljenja, ki za aktivacijo na svetlobo občutljivega sredstva uporablja svetlobo (običajno svetlobo laserja).
It is used on its own in newly diagnosed adults and as an ‘add-on’ therapy in adults and children aged 6 years and above already receiving other antiepilepsy medicines.
Uporablja se kot samostojno zdravilo pri odraslih z nedavno diagnosticirano boleznijo in kot dodatna terapija pri odraslih in otrocih, starejših od 6 let, ki že jemljejo druga zdravila proti epilepsiji.
It is used on its own in newly diagnosed adults and as an ‘add-on’ therapy in adults and children aged six years and above already receiving other anti-epilepsy medicines.
Uporablja se kot samostojno zdravilo pri odraslih z na novo diagnosticirano boleznijo in kot dodatna terapija pri odraslih in otrocih, starejših od šest let, ki že jemljejo druga zdravila proti epilepsiji.
It is used on its own or combination with another cancer medicine, dabrafenib.
Uporablja se samostojno ali v kombinaciji z drugim zdravilom za zdravljenje raka, dabrafenibom.
It is used on its own or in combination with trametinib, another cancer medicine to treat melanoma.
Uporablja se kot samostojno zdravilo ali v kombinaciji z drugim zdravilom za zdravljenje melanoma, trametinibom.
It is used on its own to treat patients with: metastatic cancer of the ovary (when the cancer has spread to other parts of the body).
Uporablja se kot samostojno zdravilo za zdravljenje bolnikov z: metastatskim rakom jajčnikov (rakom, ki se je razširil na druge dele telesa).
It is used only in patients who have not received anti-HIV treatment before or whose disease is not expected to be resistant to any of the antiviral agents contained in Stribild.
Zdravilo Stribild se uporablja samo pri bolnikih, ki predhodno še niso prejemali zdravil proti virusu HIV, ali pri bolnikih, pri katerih se ne pričakuje pojav odpornosti na katero od protivirusnih učinkovin v zdravilu.
It is used specifically in adults with a type of MS known as relapsing-remitting MS, where the patient has flare-ups of symptoms (relapses) followed by periods of recovery (remissions).
Zdravilo Plegridy se uporablja samo pri odraslih z vrsto MS, imenovano recidivno remitentna MS, pri kateri ima bolnik napade (recidive) simptomov, ki jim sledijo obdobja izboljšanja (remisije).
It is used specifically in adults with advanced cancer in the following situations: when the cancer has a mutation in the gene for a protein called EGFR and has not been previously treated with tyrosine kinase inhibitor medicines. when the cancer is of a squamous cell type (from cells of the lining of the lungs) and has worsened despite treatment with platinum-based chemotherapy.
Zlasti se uporablja pri odraslih z napredovalim rakom v naslednjih pogojih: če ima rak mutacijo gena za beljakovino, imenovano EGFR, in bolnik še ni bil zdravljen z zaviralci tirozin-kinaze; če gre za raka skvamoznih celic (na pljučni mreni), ki se je poslabšal kljub zdravljenju s kemoterapijo na osnovi platine.
It is used to delay birth in adult women who are 24 to 33 weeks pregnant, when they show signs that they may give birth pre- term (prematurely).
Zdravilo Atosiban SUN se uporablja za odložitev poroda pri odraslih ženskah, ki so noseče 24 do 33 tednov, če izkazujejo znake, da bi utegnilo priti do prezgodnjega nastopa poroda.